Atlantic Coast Acquisition Corp. Warrants (ABPWW) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Atlantic Coast Acquisition Corp. Warrants (ABPWW:NASDAQ), powered by AI.

Current Price
$0.01
Sector
Healthcare
What is the Atlantic Coast Acquisition Corp. Warrants stock price forecast?

Atlantic Coast Acquisition Corp. Warrants is currently trading at $0.01. View real-time AI analysis on Alpha Lenz.

What is Atlantic Coast Acquisition Corp. Warrants insider trading activity?

View the latest insider trading data for Atlantic Coast Acquisition Corp. Warrants on Alpha Lenz.

What is Atlantic Coast Acquisition Corp. Warrants's P/E ratio?

View Atlantic Coast Acquisition Corp. Warrants's valuation metrics on Alpha Lenz.

Atlantic Coast Acquisition Corp. Warrants

NASDAQ · ABPWW
$0.01+0.00(+0.00%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Atlantic Coast Acquisition Corp. Warrants's future dividend policy...
Alpha Chat Insight

Atlantic Coast Acquisition Corp. Warrants's ROE is 13.8%. Explore profitability and growth together.

Ask for details

Company Overview

Atlantic Coastal Acquisition Corp. Warrants expiring September 2023 represent a financial instrument tied to equity, offering holders the right but not the obligation to purchase company shares at a predetermined price, subject to conditions specified up until the expiry date. Warrants like these typically serve as a strategic investment tool, enabling investors to leverage potential equity value growth with upfront limited cost, compared to direct stock purchase. In context of Special Purpose Acquisition Companies (SPACs), the issuing entity, Atlantic Coastal Acquisition Corp., focuses on merger activities, particularly in sectors bordering the Atlantic coastline. These warrants integrate into the broader financial landscape by allowing speculative or hedging positions on the company’s future success in closing deals and effectively increasing its share value. Such financial derivatives add liquidity and enable diverse trading strategies, thus playing a critical role in the dynamics of SPAC-related equities within their expiration horizon. While the warrants’ expiry in September 2023 limits their operational timeline, they remain a pivotal part of the financial toolkit for managing exposure and risk in this niche market segment.

CEOMr. Jin Wook Suk
SectorHealthcare
IndustryBiotechnology
Employees6

Company Statistics

FY 2024

Profile

N/AMarket Cap
$183.00KRevenue
0.00Shares Out
6Employees

Margins

N/AGross
-3133.33%EBITDA
-5421.31%Operating
-3951.91%Pre-Tax
-3951.91%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-180.44%ROA
13.84%ROE
-170.78%ROIC

Financial Health

$2.85MCash & Cash Equivalents
$16.76MNet Debt
-131.19%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Atlantic Coast Acquisition Corp. Warrants (ticker: ABPWW) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 6 employees.

The current price is $0.012 with a P/E ratio of -x and P/B of -x.

ROE is 13.84% and operating margin is -5421.31%. Annual revenue is $183,000.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Atlantic Coast Acquisition Corp. Warrants (ABPWW) Stock Forecast 2026 $0.01 — Price, Financials & Analyst Targets | Alpha Lenz